RunPod provides a cloud infrastructure that enables seamless deployment and scaling of AI workloads with GPU-powered pods. By offering access to a wide array of NVIDIA GPUs, such as the A100 and H100, RunPod supports training and deploying machine learning models with minimal latency and high performance. The platform emphasizes ease of use, allowing users to spin up pods in seconds and scale them dynamically to meet demand. With features like autoscaling, real-time analytics, and serverless scaling, RunPod is an ideal solution for startups, academic institutions, and enterprises seeking a flexible, powerful, and affordable platform for AI development and inference.
Learn more
SciSure is reshaping the future of laboratories worldwide with forward-thinking digital solutions. Our Digital Lab Platform (DLP) unites key tools such as Electronic Lab Notebook (ELN), Laboratory Information Management Systems (LIMS), and advanced technologies like AI and machine learning. Built for seamless compatibility with your lab's hardware and software, the platform enhances flexibility, security, and efficiency. By consolidating and optimizing your research and development workflows within a secure and compliant environment, we help researchers dedicate more time to innovation. Our expert team is committed to supporting you at every stage of your digital lab transformation.
Learn more
Illumina DRAGEN Secondary Analysis
The Illumina DRAGEN Secondary Analysis system offers precise, thorough, and highly efficient processing of next-generation sequencing data. Utilizing a graph reference genome alongside machine learning techniques, it achieves remarkable accuracy. The workflow is exceptionally streamlined, capable of completely analyzing a 34x whole human genome in approximately 30 minutes when using the DRAGEN server v4. Additionally, it enhances this workflow by compressing FASTQ file sizes by up to five times. This system is adept at analyzing a variety of NGS data types, including whole genomes, exomes, methylomes, and transcriptomes. It is designed to be compatible with the user's preferred platform and is scalable to meet varying requirements. DRAGEN analysis consistently ranks as a leader in accuracy for both germline and somatic variant detection, as evidenced by its performance in industry competitions conducted by precisionFDA. This advanced analysis solution empowers laboratories of all sizes and specialties to maximize the potential of their genomic datasets. Moreover, the implementation of highly adaptable field-programmable gate array (FPGA) technology allows DRAGEN to deliver hardware-accelerated genomic analysis algorithms, further enhancing its performance. Such advancements position DRAGEN as a vital tool in the ever-evolving field of genomics.
Learn more
Evo 2
Evo 2 represents a cutting-edge genomic foundation model that excels in making predictions and designing tasks related to DNA, RNA, and proteins. It employs an advanced deep learning architecture that allows for the modeling of biological sequences with single-nucleotide accuracy, achieving impressive scaling of both compute and memory resources as the context length increases. With a robust training of 40 billion parameters and a context length of 1 megabase, Evo 2 has analyzed over 9 trillion nucleotides sourced from a variety of eukaryotic and prokaryotic genomes. This extensive dataset facilitates Evo 2's ability to conduct zero-shot function predictions across various biological types, including DNA, RNA, and proteins, while also being capable of generating innovative sequences that maintain a plausible genomic structure. The model's versatility has been showcased through its effectiveness in designing operational CRISPR systems and in the identification of mutations that could lead to diseases in human genes. Furthermore, Evo 2 is available to the public on Arc's GitHub repository, and it is also incorporated into the NVIDIA BioNeMo framework, enhancing its accessibility for researchers and developers alike. Its integration into existing platforms signifies a major step forward for genomic modeling and analysis.
Learn more
